Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 621

1.

Preconception Lifestyle and Cardiovascular Health in the Offspring of Overweight and Obese Women.

van Elten TM, van de Beek C, Geelen A, Gemke RJBJ, Groen H, Hoek A, Mol BW, van Poppel MNM, Roseboom TJ.

Nutrients. 2019 Oct 14;11(10). pii: E2446. doi: 10.3390/nu11102446.

2.

New Fissure-attached Nodules in Lung Cancer Screening: A Brief Report from The NELSON Study.

Han D, Heuvelmans MA, van der Aalst CM, van Smoorenburg LH, Dorrius MD, Rook M, Nackaerts K, Walter JE, Groen HJM, Vliegenthart R, de Koning HJ, Oudkerke M.

J Thorac Oncol. 2019 Oct 10. pii: S1556-0864(19)33521-X. doi: 10.1016/j.jtho.2019.09.193. [Epub ahead of print]

PMID:
31606605
3.

Cost-effectiveness analysis of the first-line EGFR-TKIs in patients with non-small cell lung cancer harbouring EGFR mutations.

Holleman MS, Al MJ, Zaim R, Groen HJM, Uyl-de Groot CA.

Eur J Health Econ. 2019 Sep 20. doi: 10.1007/s10198-019-01117-3. [Epub ahead of print]

PMID:
31541309
4.

Effects of maternal lifestyle interventions on child neurobehavioral development: Follow-up of randomized controlled trials.

Menting MD, van de Beek C, Rono K, Hoek A, Groen H, Painter RC, Girchenko P, Lahti-Pulkkinen M, Koivusalo SB, Räikkönen K, Eriksson JG, Roseboom TJ, Heinonen K.

Scand J Psychol. 2019 Sep 9. doi: 10.1111/sjop.12575. [Epub ahead of print]

PMID:
31498898
5.

Anti-oxidative function of follicular fluid HDL and outcomes of modified natural cycle-IVF.

Nagy RA, van Montfoort APA, Groen H, Homminga I, Andrei D, Mistry RH, Anderson JLC, Hoek A, Tietge UJF.

Sci Rep. 2019 Sep 6;9(1):12817. doi: 10.1038/s41598-019-49091-3.

6.

Impact of Hypertension and Preeclampsia Intervention Trial At Near Term-I (HYPITAT-I) on obstetric management and outcome in The Netherlands.

de Sonnaville CMW, Hukkelhoven CW, Vlemmix F, Groen H, Schutte JM, Mol BW, van Pampus MG.

Ultrasound Obstet Gynecol. 2019 Sep 4. doi: 10.1002/uog.20417. [Epub ahead of print]

PMID:
31486156
7.

Randomised phase 3 study of adjuvant chemotherapy with or without nadroparin in patients with completely resected non-small-cell lung cancer: the NVALT-8 study.

Groen HJM, van der Heijden EHFM, Klinkenberg TJ, Biesma B, Aerts J, Verhagen A, Kloosterziel C, Pieterman R, van den Borne B, Smit HJM, Hoekstra O, Schramel FMNH, van der Noort V, van Tinteren H, Smit EF, Dingemans AC; NVALT Study Group, the Netherlands.

Br J Cancer. 2019 Aug;121(5):372-377. doi: 10.1038/s41416-019-0533-3. Epub 2019 Jul 24.

PMID:
31337877
8.

Childhood adversity and women's cardiometabolic health in adulthood: associations with health behaviors, psychological distress, mood symptoms, and personality.

van Dammen L, Bush NR, de Rooij SR, Mol BWJ, Groen H, Hoek A, Roseboom TJ.

BMC Womens Health. 2019 Jul 23;19(1):102. doi: 10.1186/s12905-019-0797-z.

9.

Circulating tumor cells in advanced non-small cell lung cancer patients are associated with worse tumor response to checkpoint inhibitors.

Tamminga M, de Wit S, Hiltermann TJN, Timens W, Schuuring E, Terstappen LWMM, Groen HJM.

J Immunother Cancer. 2019 Jul 10;7(1):173. doi: 10.1186/s40425-019-0649-2.

10.

Factors determining the effect of prophylactic cranial irradiation (PCI) in patients with stage-III nonsmall cell lung cancer: exploratory subgroup analyses of the NVALT-11/DLCRG-02 phase-III study.

Witlox WJA, Ramaekers BLT, Groen HJM, Dingemans AM, Praag J, Belderbos J, van der Noort V, van Tinteren H, Joore MA, De Ruysscher DKM.

Acta Oncol. 2019 Jul 1:1-4. doi: 10.1080/0284186X.2019.1629016. [Epub ahead of print] No abstract available.

PMID:
31256737
11.

EPAC-lung: pooled analysis of circulating tumour cells in advanced non-small cell lung cancer.

Lindsay CR, Blackhall FH, Carmel A, Fernandez-Gutierrez F, Gazzaniga P, Groen HJM, Hiltermann TJN, Krebs MG, Loges S, López-López R, Muinelo-Romay L, Pantel K, Priest L, Riethdorf S, Rossi E, Terstappen L, Wikman H, Soria JC, Farace F, Renehan A, Dive C, Besse B, Michiels S.

Eur J Cancer. 2019 Aug;117:60-68. doi: 10.1016/j.ejca.2019.04.019. Epub 2019 Jun 27.

12.

The prognostic value of early onset, CT derived loss of muscle and adipose tissue during chemotherapy in metastatic non-small cell lung cancer.

Degens JHRJ, Sanders KJC, de Jong EEC, Groen HJM, Smit EF, Aerts JG, Schols AMWJ, Dingemans AC.

Lung Cancer. 2019 Jul;133:130-135. doi: 10.1016/j.lungcan.2019.05.021. Epub 2019 May 20.

13.

Molecular tumour boards and molecular diagnostics for patients with cancer in the Netherlands: experiences, challenges, and aspirations.

Willemsen AECAB, Krausz S, Ligtenberg MJL, Grünberg K, Groen HJM, Voest EE, Cuppen EPJG, van Laarhoven HWM, van Herpen CML.

Br J Cancer. 2019 Jul;121(1):34-36. doi: 10.1038/s41416-019-0489-3. Epub 2019 May 27.

PMID:
31130724
14.

Methods of computed tomography screening and management of lung cancer in Tianjin: design of a population-based cohort study.

Du Y, Zhao Y, Sidorenkov G, de Bock GH, Cui X, Huang Y, Dorrius MD, Rook M, Groen HJM, Heuvelmans MA, Vliegenthart R, Chen K, Xie X, Liu S, Oudkerk M, Ye Z.

Cancer Biol Med. 2019 Feb;16(1):181-188. doi: 10.20892/j.issn.2095-3941.2018.0237.

15.

Circulating tumor cells are prognostic in SCLC, but still lack clinical application.

Tamminga M, Groen HJM.

Ann Oncol. 2019 Jul 1;30(7):1031-1033. doi: 10.1093/annonc/mdz162. No abstract available.

PMID:
31095269
16.

Association between parity and persistent weight gain at age 40-60 years: a longitudinal prospective cohort study.

Zoet GA, Paauw ND, Groenhof K, Franx A, Gansevoort RT, Groen H, Van Rijn B, Lely T.

BMJ Open. 2019 May 5;9(5):e024279. doi: 10.1136/bmjopen-2018-024279.

17.

Air Pollution and Adenocarcinoma in Never-Smokers.

Groen HJM, Hiltermann TJN.

J Thorac Oncol. 2019 May;14(5):761-763. doi: 10.1016/j.jtho.2019.02.007. No abstract available.

PMID:
31027739
18.

Early imaging biomarkers of lung cancer, COPD and coronary artery disease in the general population: rationale and design of the ImaLife (Imaging in Lifelines) Study.

Xia C, Rook M, Pelgrim GJ, Sidorenkov G, Wisselink HJ, van Bolhuis JN, van Ooijen PMA, Guo J, Oudkerk M, Groen H, van den Berge M, van der Harst P, Dijkstra H, Vonder M, Heuvelmans MA, Dorrius MD, De Deyn PP, de Bock GH, Dotinga A, Vliegenthart R.

Eur J Epidemiol. 2019 Apr 23. doi: 10.1007/s10654-019-00519-0. [Epub ahead of print]

PMID:
31016436
19.

Neonatal developmental and behavioral outcomes of immediate delivery versus expectant monitoring in mild hypertensive disorders of pregnancy: 2-year outcomes of the HYPITAT-II trial.

Zwertbroek EF, Franssen MTM, Broekhuijsen K, Langenveld J, Bremer H, Ganzevoort W, van Loon AJ, van Pampus MG, Rijnders RJP, Sikkema MJ, Scherjon SA, Woiski MD, Mol BWJ, van Baar AL, Groen H; HYPITAT-II Study Group.

Am J Obstet Gynecol. 2019 Aug;221(2):154.e1-154.e11. doi: 10.1016/j.ajog.2019.03.024. Epub 2019 Mar 30.

PMID:
30940558
20.

Prevalence and prognostic value of PD-L1 expression in molecular subtypes of metastatic large cell neuroendocrine carcinoma (LCNEC).

Hermans BCM, Derks JL, Thunnissen E, van Suylen RJ, den Bakker MA, Groen HJM, Smit EF, Damhuis RA, van den Broek EC, Stallinga CM, Roemen GM, Speel EJM, Dingemans AC; PALGA-group.

Lung Cancer. 2019 Apr;130:179-186. doi: 10.1016/j.lungcan.2019.02.022. Epub 2019 Feb 21.

PMID:
30885341
21.

First-line tyrosine kinase inhibitors in EGFR mutation-positive non-small-cell lung cancer: a network meta-analysis.

Holleman MS, van Tinteren H, Groen HJ, Al MJ, Uyl-de Groot CA.

Onco Targets Ther. 2019 Feb 20;12:1413-1421. doi: 10.2147/OTT.S189438. eCollection 2019. Review.

22.

Recurrence risk of preeclampsia in a linked population-based cohort: Effects of first pregnancy maximum diastolic blood pressure and gestational age.

Bernardes TP, Mol BW, Ravelli ACJ, van den Berg PP, Boezen HM, Groen H.

Pregnancy Hypertens. 2019 Jan;15:32-36. doi: 10.1016/j.preghy.2018.10.010. Epub 2018 Nov 2.

PMID:
30825924
23.

The effects of a pre-conception lifestyle intervention in women with obesity and infertility on perceived stress, mood symptoms, sleep and quality of life.

van Dammen L, Wekker V, de Rooij SR, Mol BWJ, Groen H, Hoek A, Roseboom TJ.

PLoS One. 2019 Feb 25;14(2):e0212914. doi: 10.1371/journal.pone.0212914. eCollection 2019.

24.

Delivery or expectant management for prevention of adverse maternal and neonatal outcomes in hypertensive disorders of pregnancy: an individual participant data meta-analysis.

Bernardes TP, Zwertbroek EF, Broekhuijsen K, Koopmans C, Boers K, Owens M, Thornton J, van Pampus MG, Scherjon SA, Wallace K, Langenveld J, van den Berg PP, Franssen MTM, Mol BWJ, Groen H.

Ultrasound Obstet Gynecol. 2019 Apr;53(4):443-453. doi: 10.1002/uog.20224.

25.

Induction of Peripheral Effector CD8 T-cell Proliferation by Combination of Paclitaxel, Carboplatin, and Bevacizumab in Non-small Cell Lung Cancer Patients.

de Goeje PL, Poncin M, Bezemer K, Kaijen-Lambers MEH, Groen HJM, Smit EF, Dingemans AC, Kunert A, Hendriks RW, Aerts JGJV.

Clin Cancer Res. 2019 Apr 1;25(7):2219-2227. doi: 10.1158/1078-0432.CCR-18-2243. Epub 2019 Jan 14.

PMID:
30642911
26.

Preconception lifestyle intervention reduces long term energy intake in women with obesity and infertility: a randomised controlled trial.

van Elten TM, Karsten MDA, Geelen A, Gemke RJBJ, Groen H, Hoek A, van Poppel MNM, Roseboom TJ.

Int J Behav Nutr Phys Act. 2019 Jan 8;16(1):3. doi: 10.1186/s12966-018-0761-6.

27.

Surgical experience and patient-related restrictions predict the adequacy of cervical mediastinoscopy in non-small cell lung carcinoma lymph node staging.

Klinkenberg TJ, Bouma W, Van De Wauwer C, Wolf RFE, Mariani MA, Groen HJM.

J Cardiothorac Surg. 2018 Dec 29;13(1):134. doi: 10.1186/s13019-018-0821-7.

28.

Persisting new nodules in incidence rounds of the NELSON CT lung cancer screening study.

Walter JE, Heuvelmans MA, Ten Haaf K, Vliegenthart R, van der Aalst CM, Yousaf-Khan U, van Ooijen PMA, Nackaerts K, Groen HJM, De Bock GH, de Koning HJ, Oudkerk M.

Thorax. 2019 Mar;74(3):247-253. doi: 10.1136/thoraxjnl-2018-212152. Epub 2018 Dec 27.

PMID:
30591535
29.

Trajectory of Cardiovascular Risk Factors After Hypertensive Disorders of Pregnancy.

Groenhof TKJ, Zoet GA, Franx A, Gansevoort RT, Bots ML, Groen H, Lely AT; PREVEND Group.

Hypertension. 2019 Jan;73(1):171-178. doi: 10.1161/HYPERTENSIONAHA.118.11726.

PMID:
30571544
30.

Screening for Early Lung Cancer, Chronic Obstructive Pulmonary Disease, and Cardiovascular Disease (the Big-3) Using Low-dose Chest Computed Tomography: Current Evidence and Technical Considerations.

Heuvelmans MA, Vonder M, Rook M, Groen HJM, De Bock GH, Xie X, Ijzerman MJ, Vliegenthart R, Oudkerk M.

J Thorac Imaging. 2019 May;34(3):160-169. doi: 10.1097/RTI.0000000000000379.

PMID:
30550403
31.

Cardiometabolic Health in Relation to Lifestyle and Body Weight Changes 3⁻8 Years Earlier.

Van Elten TM, Van Poppel MNM, Gemke RJBJ, Groen H, Hoek A, Mol BW, Roseboom TJ.

Nutrients. 2018 Dec 10;10(12). pii: E1953. doi: 10.3390/nu10121953.

32.

Single tube liquid biopsy for advanced non-small cell lung cancer.

de Wit S, Rossi E, Weber S, Tamminga M, Manicone M, Swennenhuis JF, Groothuis-Oudshoorn CGM, Vidotto R, Facchinetti A, Zeune LL, Schuuring E, Zamarchi R, Hiltermann TJN, Speicher MR, Heitzer E, Terstappen LWMM, Groen HJM.

Int J Cancer. 2019 Jun 15;144(12):3127-3137. doi: 10.1002/ijc.32056. Epub 2019 Jan 28.

PMID:
30536653
33.

Systematic evaluation of the efficacy-effectiveness gap of systemic treatments in metastatic nonsmall cell lung cancer.

Cramer-van der Welle CM, Peters BJM, Schramel FMNH, Klungel OH, Groen HJM, van de Garde EMW; Santeon NSCLC Study Group; Santeon NSCLC study group.

Eur Respir J. 2018 Dec 20;52(6). pii: 1801100. doi: 10.1183/13993003.01100-2018. Print 2018 Dec.

34.

89Zr-atezolizumab imaging as a non-invasive approach to assess clinical response to PD-L1 blockade in cancer.

Bensch F, van der Veen EL, Lub-de Hooge MN, Jorritsma-Smit A, Boellaard R, Kok IC, Oosting SF, Schröder CP, Hiltermann TJN, van der Wekken AJ, Groen HJM, Kwee TC, Elias SG, Gietema JA, Bohorquez SS, de Crespigny A, Williams SP, Mancao C, Brouwers AH, Fine BM, de Vries EGE.

Nat Med. 2018 Dec;24(12):1852-1858. doi: 10.1038/s41591-018-0255-8. Epub 2018 Nov 26.

PMID:
30478423
35.

KRAS Mutation as a Resistance Mechanism to BRAF/MEK Inhibition in NSCLC.

Niemantsverdriet M, Schuuring E, Elst AT, van der Wekken AJ, van Kempen LC, van den Berg A, Groen HJM.

J Thorac Oncol. 2018 Dec;13(12):e249-e251. doi: 10.1016/j.jtho.2018.07.103. No abstract available.

PMID:
30467046
36.

Assessing Lung Cancer Screening Programs under Uncertainty in a Heterogeneous Population.

Broekhuizen H, Groothuis-Oudshoorn CGM, Vliegenthart R, Groen HJM, IJzerman MJ.

Value Health. 2018 Nov;21(11):1269-1277. doi: 10.1016/j.jval.2018.01.021.

PMID:
30442273
37.

Relationship between the number of new nodules and lung cancer probability in incidence screening rounds of CT lung cancer screening: The NELSON study.

Walter JE, Heuvelmans MA, de Bock GH, Yousaf-Khan U, Groen HJM, van der Aalst CM, Nackaerts K, van Ooijen PMA, de Koning HJ, Vliegenthart R, Oudkerk M.

Lung Cancer. 2018 Nov;125:103-108. doi: 10.1016/j.lungcan.2018.05.007. Epub 2018 May 14.

38.

Effects of a preconception lifestyle intervention in obese infertile women on diet and physical activity; A secondary analysis of a randomized controlled trial.

van Elten TM, Karsten MDA, Geelen A, van Oers AM, van Poppel MNM, Groen H, Gemke RJBJ, Mol BW, Mutsaerts MAQ, Roseboom TJ, Hoek A; LIFEstyle study group.

PLoS One. 2018 Nov 7;13(11):e0206888. doi: 10.1371/journal.pone.0206888. eCollection 2018.

39.

Long-term effects of a preconception lifestyle intervention on cardiometabolic health of overweight and obese women.

Wekker V, Huvinen E, van Dammen L, Rono K, Painter RC, Zwinderman AH, van de Beek C, Sarkola T, Mol BWJ, Groen H, Hoek A, Koivusalo SB, Roseboom TJ, Eriksson JG.

Eur J Public Health. 2019 Apr 1;29(2):308-314. doi: 10.1093/eurpub/cky222.

40.

A lifestyle intervention improves sexual function of women with obesity and infertility: A 5 year follow-up of a RCT.

Wekker V, Karsten MDA, Painter RC, van de Beek C, Groen H, Mol BWJ, Hoek A, Laan E, Roseboom TJ.

PLoS One. 2018 Oct 23;13(10):e0205934. doi: 10.1371/journal.pone.0205934. eCollection 2018.

41.

Reply to A. Addeo et al, H. Zeng et al, and C.G. Rusthoven.

De Ruysscher DK, Groen HJ.

J Clin Oncol. 2018 Oct 22:JCO1800863. doi: 10.1200/JCO.18.00863. [Epub ahead of print] No abstract available.

PMID:
30346900
42.

Maternal right ventricular function, uteroplacental circulation in first trimester and pregnancy outcome in women with congenital heart disease.

Siegmund AS, Kampman MAM, Oudijk MA, Mulder BJM, Sieswerda GTJ, Koenen SV, Hummel YM, de Laat MWM, Sollie-Szarynska KM, Groen H, van Dijk APJ, van Veldhuisen DJ, Bilardo CM, Pieper PG.

Ultrasound Obstet Gynecol. 2019 Sep;54(3):359-366. doi: 10.1002/uog.20148.

PMID:
30334300
43.

A Phase I Dose-Escalation Study of Veliparib Combined with Carboplatin and Etoposide in Patients with Extensive-Stage Small Cell Lung Cancer and Other Solid Tumors.

Atrafi F, Groen HJM, Byers LA, Garralda E, Lolkema MP, Sangha RS, Viteri S, Chae YK, Camidge DR, Gabrail NY, Hu B, Tian T, Nuthalapati S, Hoening E, He L, Komarnitsky P, Calles A.

Clin Cancer Res. 2019 Jan 15;25(2):496-505. doi: 10.1158/1078-0432.CCR-18-2014. Epub 2018 Oct 16.

PMID:
30327308
44.

Classification of Cells in CTC-Enriched Samples by Advanced Image Analysis.

de Wit S, Zeune LL, Hiltermann TJN, Groen HJM, Dalum GV, Terstappen LWMM.

Cancers (Basel). 2018 Oct 10;10(10). pii: E377. doi: 10.3390/cancers10100377.

45.

Quantitative proteomics analysis identifies MUC1 as an effect sensor of EGFR inhibition.

de Boer HR, Pool M, Joosten E, Everts M, Samplonius DF, Helfrich W, Groen HJM, van Cooten S, Fusetti F, Fehrmann RSN, de Vries EGE, van Vugt MATM.

Oncogene. 2019 Feb;38(9):1477-1488. doi: 10.1038/s41388-018-0522-7. Epub 2018 Oct 10.

PMID:
30305724
46.

Respiratory level tracking with visual biofeedback for consistent breath-hold level with potential application in image-guided interventions.

Heerink WJ, Dorrius MD, Groen HJM, Van Ooijen PMA, Vliegenthart R, Oudkerk M.

Eur Radiol Exp. 2018 Sep 5;2:22. doi: 10.1186/s41747-018-0052-7. eCollection 2018 Dec.

47.

Prophylactic cranial irradiation (PCI) in locally advanced non-small cell lung cancer: time for hope?

De Ruysscher DK, Groen HJ.

Oncotarget. 2018 Aug 17;9(64):32274-32275. doi: 10.18632/oncotarget.25866. eCollection 2018 Aug 17. No abstract available.

48.

[An enlarged thymus associated with Graves' disease].

Wouters MPAM, Wolffenbuttel BHR, Links TP, Groen HJM, Wouters RSME.

Ned Tijdschr Geneeskd. 2018 Jul 20;162. pii: D2905. Dutch.

PMID:
30182634
49.

Developing Ultrasensitive Library-Aliquot-Based Droplet Digital PCR for Detecting T790M in Plasma-Circulating Tumor DNA of Non-small-Cell-Lung-Cancer Patients.

Yang K, Li J, Zhao J, Ren P, Wang Z, Wei B, Dong B, Sun R, Wang X, Groen HJM, Ma J, Guo Y.

Anal Chem. 2018 Oct 2;90(19):11203-11209. doi: 10.1021/acs.analchem.8b01776. Epub 2018 Sep 11.

PMID:
30156405
50.

A systematic review and meta-analysis of lifestyle interventions in women of reproductive age with overweight or obesity: the effects on symptoms of depression and anxiety.

van Dammen L, Wekker V, de Rooij SR, Groen H, Hoek A, Roseboom TJ.

Obes Rev. 2018 Dec;19(12):1679-1687. doi: 10.1111/obr.12752. Epub 2018 Aug 28.

PMID:
30155959

Supplemental Content

Support Center